1. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
   Zhongyi Tong et al, 2015, IJMS CrossRef
2. Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments
   Kyung-Min Kim et al, 2016, Cancer Cell Int CrossRef
3. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
   ROBERTO GAMBARI et al, 2016 CrossRef
4. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer
   Vinoth Prasanna Gunasekaran et al, 2017, European Journal of Pharmaceutical Sciences CrossRef
5. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
   Bhavesh K Ahir et al, 2017, Crit Rev Oncol Hematol CrossRef
6. microRNAs: Emerging players in oral cancers and inflammatory disorders
   Varun Kulkarni et al, 2017, Tumour Biol. CrossRef
7. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection
   Elizabeth G Graham-Gurysh et al, 2018, Mol. Pharmaceutics CrossRef
8. Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention
   Bernhard Biersack, 2016, Non-coding RNA Research CrossRef
9. A Targeted DNAzyme-Nanocomposite Probe Equipped with Built-in Zn2+ Arsenal for Combined Treatment of Gene Regulation and Drug Delivery
   Zhi-Mei He et al, 2016, Sci Rep CrossRef
10. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
    Amanda Shea et al, 2016, Cancer Med CrossRef
11. Desregulación de microARN en el cáncer: un enfoque terapéutico y diagnóstico
    Luis Tume et al, 2016, Gaceta Mexicana de Oncología CrossRef
12. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients
    Athina Markou et al, 2016 CrossRef
13. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme
    Marek Mazurek et al, 2020, IJMS CrossRef
14. null
    YING ZHANG et al, 2017 CrossRef
15. The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations
    Andrei Buruiană et al, 2020, IJMS CrossRef
16. The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells
    Michelle S. Liberio et al, 2015, Oncotarget CrossRef
17. Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
    Xinyu Yang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
18. Exosomal noncoding RNAs: key players in glioblastoma drug resistance
    Ahmad Movahedpour et al, 2021, Mol Cell Biochem CrossRef
19. Role of microRNAs in glioblastoma
    Ming Chen et al, 2021, Oncotarget CrossRef
20. Anticancer roles of let‑7f‑1‑3p in non‑small cell lung cancer via direct targeting of integrin β1
    Yanan Yang et al, 2021, Exp Ther Med CrossRef
21. Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.
    Yulun Huang et al, 2021, Adv Sci (Weinh) CrossRef
22. null
    Rajat Chauhan et al, 2018 CrossRef
23. The role of microRNA in the pathogenesis of glial brain tumors
    Ozal Beylerli et al, 2022, Non-coding RNA Research CrossRef
24. Non-coding RNAs Enhance the Apoptosis Efficacy of Therapeutic Agents Used for the Treatment of Glioblastoma Multiform
    Shokoofeh Ghaemi et al, 2022, Journal of Drug Targeting CrossRef
25. null
    Smruti Rekha Rout et al, 2022 CrossRef
26. miR-30a-5p Augments the Anti-inflammatory Effects of Dexmedetomidine in LPS-induced BV2 Cells
    Ji-Eun Kim et al, 2022, Korean J Clin Lab Sci CrossRef
27. miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2
    Qingwei Wang et al, 2023, Heliyon CrossRef
28. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma
    Ravi Raj Singh et al, 2024, Bioactive Materials CrossRef